Ovarian and uterine leiomyosarcoma: which one is the primary?

Shafiee MN 1 , Kah Teik C 2 , Md Zain RR 3 , Kampan N 1

Affiliations 

  • 1 Faculty of Medicine, Department of Obstetrics and Gynaecology, UKM Medical Centre, Cheras, 56000 Kuala Lumpur, Malaysia
  • 2 Faculty of Medicine, Department of Obstetrics and Gynaecology, UKM Medical Centre, Cheras, 56000 Kuala Lumpur, Malaysia, Phone: +60391455949, Fax: +60391455672
  • 3 Faculty of Medicine, Department of Pathology, UKM Medical Centre, Cheras, 56000 Kuala Lumpur, Malaysia
Horm Mol Biol Clin Investig, 2019 Aug 09;41(2).
PMID: 31398145 DOI: 10.1515/hmbci-2019-0037

Abstract

Uterine leiomyosarcoma (LMS) is rare but primary ovarian LMS is even rarer constituting less than 0.1% of all gynecologic disorders. Neither histologic features nor immunohistochemistry could be utilized to distinguish between uterine or ovarian origin. We illustrate a clinical case of metastatic LMS to the ovary in a woman with underlying uterine fibroid presenting with anemia with heavy menses.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications